The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"

نویسنده

  • Jean O. Lanjouw
چکیده

TRIPs, the intellectual property component of the Uruguay round GATT Treaty, gave rise to an acrimonious debate between the developed countries and less developed countries (LDCs). On one side, business interests in the developed world claimed large losses from the imitation and use of their innovations in LDCs. They also asserted that establishing strong intellectual property rights would actually benefit the developing countries by encouraging foreign investment, the transfer of technology and greater domestic research and development (R&D). On the other side, LDC governments adamantly opposed this view, worrying about the higher prices that stronger intellectual property rights would entail and about the harm that their introduction might cause to infant high tech industries.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Access to Medicines After 2005: Opening Pandora’s Box?

Developing countries like India that did not grant patent protection for pharmaceutical products prior to the TRIPS Agreement’s entry into force, were given until 1 January 2005 to introduce such protection. The introduction of 20-year product patents for medicines in India is significant not only because of its huge population, but also because Indian companies are major suppliers of generic m...

متن کامل

Evaluation of Rights Related to Public Health and Pharmaceutical Patents and Existing Conflicts According to National and International Laws

Today, along with the relative expansion of public health around the world, various diseases such as AIDS, malaria, etc. are increasing in human societies. In this regard, the pharmaceutical industry is one of the most important industries that should be supported so that the inventors of new drugs have enough motivation to produce more effective drugs. On the other hand, the undeniable benefit...

متن کامل

Strengthening the Export Competitiveness of firms in the Indian Pharmaceutical Industry

The Indian pharmaceutical industry is one of the most vibrant knowledge driven industries in India that has witnessed consistent growth over the past three decades. The industry accounts for 8% of world's production by volume and 1.5% by value. Much of the country's pharmaceutical consumption was met by imports until the early 1970s. Between 1947-57, 99% of the 1704 drugs and pharmaceutical pat...

متن کامل

تعارض اصل حمایت از اختراعات دارویی و حقوق بشر؛ تفسیر حقوقی ماده 27 موافقت‌نامه تریپس

Today, pharmaceutical patents constitute an important part of industrial production and investment corporations have shown interest in this issue which is willing to protect these patents for assurance of investment in this area. While progress in this field has human interests, but the unconditional protection of such patents is in conflict with the right to health as one of the fundamental hu...

متن کامل

A survey of the effects of brand value on customer satisfaction in pharmaceutical and biological industries

The purpose of this study was to describe how companies in pharmaceutical and biological sectors can ensure their position in different markets by relying on sustainable, competitive advantages, resulting from the use of a well-defined marketing model with particular emphasis on brand improvement. As competition becomes more intense among companies and phenomena such as global marketing grow in...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 1997